SEC Filing Summary: LeMaitre Vascular, Inc. (LMAT)
Business Context and Reporting Period
This Form 8-K was filed on July 29, 2021, by LeMaitre Vascular, Inc., a Delaware corporation. The filing serves to announce the issuance of a press release containing preliminary financial and operational results for the quarter ended June 30, 2021.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
No material changes or comparative financial data versus the prior period are detailed in the body of this filing. The document solely acts as a notification that preliminary results for the quarter ended June 30, 2021, have been released.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended June 30, 2021.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year guidance or operational outlook provided in the press release.
- Confirm the status of the company's debt and liquidity position as detailed in the preliminary results.